Drugs / Personalized Virus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03529539 | — | cancer | EpicentRx, Inc. | No longer available | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Personalized Virus | “an oncolytic virus called PSV (short for Personalized Virus)” NCT03529539 ↗ |
| Known as | PSV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03529539 ↗ |
| Modality | Other / unclassified | “an oncolytic virus called PSV (short for Personalized Virus)” NCT03529539 ↗ |
| Route | Subcutaneous | “intratumoral or subcutaneous injection” NCT03529539 ↗ |